The MarketWatch News Department was not involved in the creation of this content. Results of 244-Patient Study to Support Planned FDA Pre-Market Approval (PMA) Application BOSTON and YOKNEAM, Israel, ...
Low-dose pyridostigmine is an effective treatment for men with underactive bladder who undergo TURP for BPH with BOO, trial findings suggest. Administration of pyridostigmine following transurethral ...
Prostate health is something every man should be aware of yet few people want to discuss. An enlarged prostate – called benign prostatic hyperplasia (BPH) – can lead to the need for surgery, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results